HIGHLIGHTS
- What: This approach has a limited capacity to improve metabolic status and may cause sustained unfavorable changes in hepatic markers . Currently, the research in progress focuses on the development of safer medications that reduce ectopic fat and/or increase energy expenditure .
- Who: Cristina Garcia-Beltran from the University of Campania Luigi Vanvitelli, Italy have published the Article: Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments, in the Journal: (JOURNAL) of 20/Oct/2023
- How: The authors described their associations with circulating biomarkers of hepatic damage which were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.